The latest news and events from ECRIN and its partners

Events

Upcoming

ICPerMed Conference 2020

25 February 2021
-
26 February 2021
Maison de la Chimie in Paris, France

The event will take place on February 25-26, 2021 in Paris, France, at La Maison de la Chimie and will demonstrate how personalised medicine will lead to the next generation of healthcare by 2030.

Past

LuxCLIN conference 'eClinical Research: getting virtual and personal'

30 May 2017
-
31 May 2017
Luxembourg

The Clinical and Epidemiological Investigation Centre (CIEC) of the Luxembourg Institute of Health (LIH) is holding the LuxCLIN conference on 'eClinical Research: getting virtual and personal'. The event will take place on Tuesday, 30 and Wednesday 31 May 2017 at Centre Hospitalier Luxembourg (CHL) in Luxembourg.

The detailed program and guidelines for registration can be found on the LuxCLIN conference website

International Clinical Trials Day 2017

19 May 2017
-
19 May 2017
Lisbon, Portugal

ECRIN's 2017 celebration of International Clinical Trials Day (ICTD) will take place in Lisbon, Portugal on 19 May 2017.

The theme of this year’s event is ‘Data sharing and reuse: attitudes and practices in multinational clinical research'. 

The aim is to engage with the public, scientific community and decision makers on issues related to (multinational) clinical trials in Europe, and to address issues related to data sharing and re-use in particular.

'Orphan drug and rare disease - Accelerating access to therapeutic innovation' 4th edition

11 May 2017
-
12 May 2017
Marseille, France

University Claude Bernard Lyon - Eudipharm, OrphanDev (part of ECRIN's French national partner, the French Clinical Research Infrastructure Network or F-CRIN), and F-CRIN's training and education unit are co-organising the 4th edition of the training course on 'Orphan drug & rare disease - Accelerating access to therapeutic innovation'.

While the methodology remains the main focus of the programme, this year will also be the opportunity to address in particular the European Medicines Agency (EMA) tools in drug development and the issues around personalised medicine.